Cefpodoxime is a third-generation cephalosporin antibiotic used to treat various bacterial infections such as respiratory tract infections, urinary tract infections, skin infections, and ear or throat infections, and it works by inhibiting bacterial cell wall synthesis, leading to bacterial death; it is commonly administered in its oral prodrug form, Cefpodoxime proxetil, which improves absorption and convenience, and its development traces back to the discovery of cephalosporin antibiotics in 1945 by Giuseppe Brotzu from the fungus Cephalosporium acremonium, followed by decades of advancement leading to third-generation cephalosporins like cefpodoxime that offer broader antibacterial activity and better resistance to beta-lactamase enzymes.
BRAND NAMES
Vantin – widely used in the US, Europe, and Asia
Orelox – used in some countries
Simpoxin – available in India and other regions
Cefprox – India
Ceporex – India
Cefspan – Middle East and Asian
MECHANISM OF ACTION
It binds to penicillin-binding proteins (PBPs) and blocks the transpeptidation step required for peptidoglycan cross-linking. This weakens the bacterial cell wall, causing it to rupture and leading to bacterial death (bactericidal action).
PHARMACOKINETICS
Absorption
Cefpodoxime is poorly absorbed in its active form, so it is given as a prodrug (cefpodoxime proxetil). After oral administration, it is absorbed from the gastrointestinal tract and converted into the active drug in the intestinal wall and liver.
Distribution
Cefpodoxime has a volume of distribution (Vd) of approximately 0.7–1.5 L/kg in adults, indicating moderate distribution throughout the body. This means the drug is not confined only to the bloodstream but also spreads into various tissues and body fluids such as lung tissue, tonsillar tissue, skin, and urinary tract fluids, where it exerts its antibacterial effect.
Metabolism
Cefpodoxime undergoes minimal metabolism in the body. After oral administration as the prodrug cefpodoxime proxetil, it is converted to the active form mainly by intestinal and hepatic esterases. The drug itself is not extensively metabolized further, and most of the active cefpodoxime remains unchanged in the systemic circulation until it is excreted. This limited metabolism contributes to its predictable pharmacokinetic profile.
Excretion
Cefpodoxime is mainly excreted through the kidneys (renal excretion) in its unchanged active form. About 80% or more of the administered dose is eliminated in urine within 24 hours.Because of its renal clearance, the drug’s dose may need adjustment in patients with reduced kidney function to avoid accumulation.
PHARMACODYNAMICS
Cefpodoxime Proxetil is bactericidal, killing bacteria by binding to PBPs and disrupting cell wall synthesis. Its effectiveness depends on maintaining drug levels above the minimum inhibitory concentration (MIC).
ADIMINISTRATION
Cefpodoxime is administered orally as tablets or oral suspension. Since it is a prodrug (cefpodoxime proxetil), it is best taken with food to improve absorption. The dose and duration vary based on age, body weight, and severity of infection, and the full course should always be completed to ensure effective treatment and prevent resistance.
DOSAGE AND STRENGTH
Cefpodoxime is mainly excreted through the kidneys (renal excretion) in its unchanged active form. About 80% or more of the administered dose is eliminated in urine within 24 hours. Because of its renal clearance, the drug’s dose may need adjustment in patients with reduced kidney function to avoid accumulation.
DRUG INTERACTIONS
Cefpodoxime interacts with antacids, proton pump inhibitors, and probenecid, which can affect its absorption or increase drug levels.
FOOD INTERACTIONS
Cefpodoxime should generally be taken with food, as food increases its absorption and improves bioavailability. Taking it on an empty stomach may reduce how much of the drug is absorbed. There are no major harmful food restrictions, but it is best to maintain a regular diet while taking the medicine and avoid skipping meals when dosing.
Contraindications
Hypersensitivity to cefpodoxime or other cephalosporin antibiotics
History of severe allergic reaction (anaphylaxis) to penicillins or beta-lactam antibiotics
Caution in patients with severe renal impairment (dose adjustment required)
Not recommended in neonates unless prescribed by a specialis
SIDE EFFECTS
Diarrhea
Nausea
Vomiting
Abdominal pain
Headache
Dizziness
Skin rash
Allergic reactions
Rare: antibiotic-associated coliti
OVER DOSE
Taking an excessive amount of Cefpodoxime Proxetil can lead to nausea
Vomiting,
Diarrhea
Abdominal pain.
TOXICITY
Cefpodoxime toxicity is generally low. Overdose may cause nausea, vomiting, diarrhea, and abdominal discomfort. Rarely, high doses can lead to neurological effects like confusion or seizures, especially in patients with kidney problems. Treatment is supportive, and the drug can be removed by hemodialysis in severe cases.
